# Arcus Biosciences, Inc.: Form 8-K, filed Aug 3, 2022

- Company: [Arcus Biosciences, Inc.](/companies/rcus.md) (CIK 1724521)
- Form: 8-K
- Filed: 2022-08-03
- Accepted by EDGAR: Aug 3, 2022, 16:16 ET
- Period: 2022-08-03
- Accession: 0000950170-22-014263
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1724521/000095017022014263/rcus-20220803.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1724521/000095017022014263/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1724521/000095017022014263/rcus-20220803.htm

Filed Aug 3, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-014263. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.
